Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Engineered Proteins Will Lead to "Synthetic Biology"

08.05.2003


Duke University Medical Center biochemists have developed a computational method to design proteins that can specifically detect a wide array of chemicals from TNT to brain chemicals involved in neurological disorders. In a paper in the May 8, 2003, issue of the journal Nature, they demonstrate the breadth of their design method, and also that such sensor proteins can be re-incorporated into cells to activate cellular signaling and genetic pathways.

The researchers said their achievement constitutes an important step toward a new technology of "synthetic biology," in which scientists construct tailor-made organisms for a variety of tasks, including as "biological sentinels." Such sentinels could find wide use in medical and environmental applications, said the paper’s senior author, Associate Professor of Biochemistry Homme Hellinga, Ph.D.

"You could imagine a bacterium engineered to respond to TNT by fluorescing that could be used to detect mines for humanitarian demining operations," he said. "Also, one might develop a plant whose cells would change its color in response to a pollutant. Such bushes could be planted around chemical facilities to detect groundwater pollution from the facility.



"Such scenarios might sound like something out of science fiction, but they are entirely feasible over the long term using computational design approaches to create sensor proteins," he said.

Hellinga is already developing a glucose-sensing protein that could be used as the basis for a monitor -- and ultimately an artificial pancreas -- for people with diabetes. Also, the TNT-sensing protein is intended to provide free-roaming underwater robots with the capability of "sniffing" a plume of TNT emanating from unexploded ordnance, tracking it to its source, to aid the U.S. Navy’s cleanup program.

The scientists’ research is supported by the Office of Naval Research, the Defense Advanced Research Projects Agency’s "Simulation of Bio-Molecular Microsystems" (SIMBIOSYS) program and the National Institutes of Health.

In the Nature paper, Hellinga and co-authors Loren Looger, Mary Dwyer and James Smith describe how they redesigned proteins from the gut bacterium E. coli. They used "periplasmic binding proteins" which are normally part of the bacterium’s chemical-sensing system by which it detects nutrients. Such protein receptors detect their target molecule via an "active site" with a precise complementary shape and binding properties that fits only that molecule, called a "ligand" -- like a key fitting a lock. Proteins consist of long strings of amino acid units that fold upon themselves to form intricate globular structures.

Basically, the computational design process developed in Hellinga’s laboratory involves redesigning a normal protein’s "lock" to fit a very different molecular key. The computational process narrows down to a manageable few the vast number of possible mutations and their corresponding structures, to fit a particular molecule.

"We call these supra-astronomical calculations, because they can produce more possible combinations than there are particles in the known universe," said Hellinga. "The proteins we work with have binding sites of about 15 amino acid residues. And each of these 15 residues could consist of any of the 20 known amino acids. And we do our calculations in three-dimensional space, so each amino acid is described by a number of different structures that we call rotamers. And we use about 6,000 rotamers to represent the 20 amino acids. So, that alone gives us 6,000 to the 15th power possible sequences."

What’s more, when the researchers factor in the further geometric complexities of how the ligand molecule docks to the active site, said Hellinga, the number of possible designs skyrockets to 10 to the hundredth power possibilities.

However, the Duke biochemists have enhanced and applied a mathematical technique called dead end elimination -- pioneered by mathematician Johan DeSmet of the University of Leuven in Belgium and his colleagues -- to drastically narrow the possible structures. Using this approach, their system can narrow the candidates down to a reasonable number with several days’ worth of calculations on a 30-processor computer network. The high-speed network, called a Beowulf cluster, consists of linked processors of the type available on high-end commercial desktop computers.

In the Nature paper, the scientists described adapting E. coli proteins to detect three very different molecules of environmental and clinical importance.

-- TNT, which is a nonbiological compound and carcinogen that the Navy is seeking to detect, as part of developing a TNT-sensing robot to aid its environmental cleanup effort.

-- lactate, which is an indicator of metabolic stress in the body and also associated with certain cancers. Thus, a lactate-sensing protein could locate metabolic distress in the body. Also, lactate has a "left-handed" and "right-handed" molecular form. Demonstrating that an engineered protein could distinguish such "chiral" forms would be of great interest to pharmaceutical firms, said Hellinga, because they must purify drugs to eliminate unwanted chiral forms that can be highly toxic.

-- serotonin, which is a neurotransmitter molecule that nerve cells use to trigger nerve impulses in neighboring cells. Fluctuating serotonin levels are associated with certain psychiatric disorders and elevated levels are indicative of certain bowel tumors.

Also, building a serotonin-sensing protein is a special design challenge, said Hellinga, because the molecule has distinct regions that are negatively or positively charged. "And frankly, we thought it was a rather dramatic achievement to build a receptor for a neurotransmitter from a bacterial protein," said Hellinga.

"We basically tried to show that this is a very general design approach," he said. "We demonstrate that, within reason, no matter what the chemical nature of the ligand, we can design an active site to specifically bind it." Also to demonstrate the adaptability of their technique, the researchers started with a number of different E. coli proteins in their design effort.

They applied their computational method to automatically generate a collection of possible designs and to narrow them down through dead end elimination to arrive at a workable number of candidates.

Then, the scientists actually constructed a selection of the candidate proteins by genetically altering E. coli to produce them. To measure the proteins’ sensing capabilities, they used a technology that they had developed earlier for the periplasmic binding proteins, and engineered the molecules to incorporate a fluorescent molecule, called a fluorophore, attached such that the protein would only fluoresce if the target molecule had plugged into the protein.

The resulting sensor proteins proved in test tube studies to have high affinity and specificity for their target molecules, said Hellinga. For example, he said, both the TNT-sensing and serotonin-sensing proteins could not be fooled by "decoy" molecules that were very closely related to TNT or serotonin in structure. Also, the lactate-detecting protein preferentially bound only to one chiral form of the molecule, proving that the design system could produce such specific sensing proteins.

The researchers used a feedback technique, called "quantitative structure-activity relationship," (QSAR) to apply data on molecular interactions in the experimental proteins to optimize the theoretical design calculations even further.

Finally, Hellinga and his colleagues sought to demonstrate that the sensor proteins could function in the machinery of living cells.

"We had shown that these proteins could function as sensors in the test tube by labeling them with fluorophores," said Hellinga. "But we were also interested in putting them back into a biological system and showing that we could modulate the behavior of that biological system. It’s an important step toward developing what we call ’synthetic biology.’"

Thus, the scientists showed that they could insert either the TNT-binding protein or the lactose-binding protein into E. coli bacteria in such a way as to activate a "reporter gene," which signaled that their molecule had become a functioning component of the bacterial genetic machinery. Such experiments proved the importance of their new design approach, said Hellinga.

"The potential implications of this technique are very broad," he said. "Essentially what we have done is establish control over molecular recognition of small molecules in biology. Such recognition is central to the most basic processes in organisms, and we have demonstrated that not only can we design highly specific receptors, but we can put them into biological systems to control them.

"Also, we have shown that we can create sensors that are exquisitely sensitive, even to the chiral forms of molecules. Such sensors could prove invaluable to pharmaceutical companies, since many drugs are chiral -- with one form being pharmacologically active and the other being either inactive or toxic."

According to Hellinga, the Duke computational design system is far superior to the other major technique -- called "directed evolution" -- used to tailor proteins to bind specific molecules. In directed evolution, researchers create a large library of candidate proteins and screen them for affinity and specificity to a target molecule.

"On the one hand directed evolution is a very elegant method, in which they’ve essentially programmed nature to give the right answer," said Hellinga. "But there are real limitations on how large a variety of possible protein structures can be surveyed. Our computational methods can overcome that limitation."

In terms of commercial applications, he said, the university is exploring the launching of a company to market and support the design methodology and applications developed by Hellinga and his colleagues.

Dennis Meredith | Duke University
Further information:
http://dukemednews.org/news/article.php?id=6549

More articles from Life Sciences:

nachricht Closing the carbon loop
08.12.2016 | University of Pittsburgh

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>